Syngene International
Syngene International offers Biologics characterization, regulated bioanalysis and clinical biomarkers. This is the analytical service business of an integrated CRO/CDMO.
Corporate information
- Company entity
- Syngene International
- Headquarters / principal office
- Headquarters city not independently verified; see the country/network tags.
- Founded
- 1993 ↗
- Ownership / capital status
- Publicly tradedPublicly listed; see issuer disclosures ↗
- Official corporate reference
- https://syngeneintl.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
Syngene International offers Biologics characterization, regulated bioanalysis and clinical biomarkers. This is the analytical service business of an integrated CRO/CDMO.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- Syngene annual report 2025
- Syngene International company page
- Syngene IPO RHP
- Syngene International — official page checked November 4, 2026